No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure

Circulation: Heart Failure

Volumn 8, Issue 6, 2015, Pages 1088-1093

  Dass, Sairia ^a   Holloway, Cameron J ^a   Cochlin, Lowri E ^a   Rider, Oliver J ^a   Mahmod, Masliza ^a   Robson, Matthew ^a   Sever, Emily ^a   Clarke, Kieran ^a   Watkins, Hugh ^a   Ashrafian, Houman ^a   Karamitsos, Theodoros D ^a   Neubauer, Stefan ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

adenosine; cardiac volume; dilated cardiomyopathy; heart failure; oxygen

Indexed keywords

ADENOSINE; OXYGEN; PHOSPHORUS 31;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENERGY TRANSFER; FEMALE; HEART FAILURE; HEART INDEX; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART VENTRICLE PRESSURE; HEART VOLUME; HUMAN; MALE; NONISCHEMIC HEART FAILURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN SUPPLY; OXYGENATION; PRIORITY JOURNAL; REST; STRESS; CARDIOMYOPATHY, DILATED; CASE CONTROL STUDY; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY;

EID: 84947814263     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.002169     Document Type: Article

References (32)

1. Rigo F, Ciampi Q, Ossena G, Grolla E, Picano E, Sicari R. Prognostic value of left and right coronary flow reserve assessment in nonischemic dilated cardiomyopathy by transthoracic Doppler echocardiography. J Card Fail. 2011;17:39-46. doi: 10.1016/j.cardfail.2010.08.003.
2. Rigo F, Gherardi S, Galderisi M. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. Eur Heart J. 2006;27:1319-1323.
3. Neglia D, Michelassi C, Trivieri MG. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186-193.
4. Sobajima M, Nozawa T, Suzuki T. Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy. J Cardiol 2010;56:280-286.
5. Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem. 1995;147:29-34.
6. Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kübler W. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol. 1983;51:1657-1662.
7. Nikolaidis LA, Doverspike A, Huerbin R, Hentosz T, Shannon RP. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation. 2002;105:2785-2790.
8. Zolk O, Solbach TF, Eschenhagen T, Weidemann A, Fromm MF. Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochem Biophys Res Commun. 2008;376:315-320. doi: 10.1016/j.bbrc.2008.08.152.
9. Holscher M, Schafer K, Krull S. Unfavourable consequences of chronic cardiac HIF-1alpha stabilization. Cardiovasc Res. 2012;94:77-86.
10. Neubauer S, Horn M, Cramer M. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190-2196.
11. Bottomley PA, Panjrath GS, Lai S, Hirsch GA, Wu K, Najjar SS, Steinberg A, Gerstenblith G, Weiss RG. Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med. 2013;5:215re3. doi: 10.1126/scitranslmed.3007328.
12. Gogna R, Madan E, Khan M, Pati U, Kuppusamy P. p53's choice of myocardial death or survival: oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. EMBO Mol Med. 2013;5:1662-1683. doi: 10.1002/emmm.201202055.
13. Holloway CJ, Montgomery HE, Murray AJ. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J. 2011;25:792-796.
14. Karamitsos TD, Dass S, Suttie J, Sever E, Birks J, Holloway CJ, Robson MD, Jerosch-Herold M, Watkins H, Neubauer S. Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61:1169-1176. doi: 10.1016/j.jacc.2012.12.024.
15. Pohmann R, von Kienlin M. Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med. 2001;45:817-826.
16. Tyler DJ, Emmanuel Y, Cochlin LE, Hudsmith LE, Holloway CJ, Neubauer S, Clarke K, Robson MD. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T. NMR Biomed. 2009;22:405-413. doi: 10.1002/nbm.1350.
17. Robson MD, Tyler DJ, Neubauer S. Ultrashort TE chemical shift imaging (UTE-CSI). Magn Reson Med. 2005;53:267-274. doi: 10.1002/mrm.20344.
18. Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, Hancock G, Beak P, Tajar A, Piechnik SK, Schneider JE, Angus B, Clarke K, Dorrell L, Neubauer S. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128:814-822. doi: 10.1161/CIRCULATIONAHA.113.001719.
19. Karamitsos TD, Leccisotti L, Arnold JR, Recio-Mayoral A, Bhamra-Ariza P, Howells RK, Searle N, Robson MD, Rimoldi OE, Camici PG, Neubauer S, Selvanayagam JB. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging. 2010;3:32-40. doi: 10.1161/CIRCIMAGING.109.860148.
20. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med. 2001;31:269-286.
21. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12:141-152.
22. Bottomley PA, Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med. 1994;32:137-141.
23. Neubauer S, Krahe T, Schindler R. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
24. Mahmod M, Francis JM, Pal N, Lewis A, Dass S, De Silva R, Petrou M, Sayeed R, Westaby S, Robson MD, Ashrafian H, Neubauer S, Karamitsos TD. Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction. J Cardiovasc Magn Reson. 2014;16:29. doi: 10.1186/1532-429X-16-29.
25. Jameel MN, Hu Q, Zhang J. Myocytes oxygenation and high energy phosphate levels during hypoxia. PLoS One. 2014;9:e101317. doi: 10.1371/journal.pone.0101317.
26. Walcher T, Manzke R, Hombach V, Rottbauer W, Wöhrle J, Bernhardt P. Myocardial perfusion reserve assessed by T2-prepared steady-state free precession blood oxygen level-dependent magnetic resonance imaging in comparison to fractional flow reserve. Circ Cardiovasc Imaging. 2012;5:580-586. doi: 10.1161/CIRCIMAGING.111.971507.
27. Arnold JR, Karamitsos TD, Bhamra-Ariza P, Francis JM, Searle N, Robson MD, Howells RK, Choudhury RP, Rimoldi OE, Camici PG, Banning AP, Neubauer S, Jerosch-Herold M, Selvanayagam JB. Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol. 2012;59:1954-1964. doi: 10.1016/j. jacc.2012.01.055.
28. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356:1140-1151. doi: 10.1056/NEJMra063052.
29. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129. doi: 10.1152/physrev.00006.2004.
30. Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ, Hoppel CL, Imai M, Rastogi S, Sabbah HN, Stanley WC. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol. 2004;287:H1538-H1543. doi: 10.1152/ajpheart.00281.2004.
31. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88:529-535.
32. Nascimben L, Ingwall JS, Pauletto P. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94:1894-1901.